title: May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?
authors.forename: Leonardo
authors.initials: L
authors.lastname: Potenza
authors.forename: Mario
authors.initials: M
authors.lastname: Luppi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Riva
authors.forename: Emanuela
authors.initials: E
authors.lastname: Ottaviani
authors.forename: Patrizia
authors.initials: P
authors.lastname: Zucchini
authors.forename: Monica
authors.initials: M
authors.lastname: Morselli
authors.forename: Francesco
authors.initials: F
authors.lastname: Volzone
authors.forename: Fabio
authors.initials: F
authors.lastname: Forghieri
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinelli
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Torelli
mesh_terms: D000208:Acute Disease; D000328:Adult; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics*; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D007958:Leukocyte Count; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D017354:Point Mutation; D011379:Prognosis; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*; D000075142:RUNX1 Translocation Partner 1 Protein; D012008:Recurrence; D012074:Remission Induction; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: C107844:AML1-ETO fusion protein, human; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; D000075142:RUNX1 Translocation Partner 1 Protein; D019009:Proto-Oncogene Proteins c-kit